儿童喘单克隆抗体治疗:目前的证据和来自特拉华州队列研究的研究结果
Samantha Y Starkey1, Abigail Strang2, Elizabeth Brown2
1Pediatrics, Nemours Children's Hospital, Delaware, Wilmington, USA.
Cureus
|December 29, 2025
概括
生物疗法显著减少了来自弱势背景的儿科喘患者的住院治疗和口服皮质类固醇使用. 这些真实数据显示,在一年内,患者的坚持良好,症状有所改善.
科学领域:
- 儿科肺病学 儿科肺病学
- 过敏和免疫学 过敏和免疫学
- 在喘管理中的现实世界的证据.
背景情况:
- 儿童喘不成比例地影响少数民族和资源不足的年轻人.
- 单克隆抗体 (生物药物) 为中度至重度喘提供了新的治疗方法.
- 对于儿科喘中的生物药物,现实世界临床数据有限.
研究的目的:
- 用生物疗法治疗中度至重度喘的儿科患者的人口特征.
- 评估生物疗法的临床结果在这个队列超过一年.
- 评估生物制剂对住院,药物使用和症状的影响.
主要方法:
- 对18岁以下的患者进行IRB批准的图表审查,这些患者接受了长达1年或更长时间的生物治疗.
- 区域贫困指数 (ADI) 用于评估社会经济劣势.
- 配对t测试分析了临床变量12个月前后治疗.
主要成果:
- 队列 (n=16) 主要是黑人 (75%),非西班牙裔 (81%),来自社会经济弱势地区 (中位数ADI为73.5).
- 在喘住院 (平均1.63到0.25) 和口服皮质类固醇疗程 (平均5.4到2.5) 中观察到的统计学上显著的减少.
- 在ED访问和肺功能测试中注意到了改善,但在统计学上并不显著. 遵守的中位数为96%.
结论:
- 在这个队列中,生物疗法导致了住院和使用皮质类固醇的显著临床改善.
- 患者主要来自少数民族和社会经济弱势群体.
- 观察到很好的药物坚持和耐受性,支持在这个人群中使用生物.
更多相关视频
相关概念视频
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:30Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...